Emgrast M 500mcg Injection
Prescription RequiredProduct introduction
Emgrast M 500mcg Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections.
Emgrast M 500mcg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include bone pain, decreased blood pressure, fever, and breathlessness. Other than this, pain or redness at the site of injection is common. But, inform your doctor if you notice a lump, swelling, or bruising that does not go away. It might not prevent you from all kinds of infection, hence inform your doctor if you notice fever, chills, shortness of breath, sore throat, and swelling around the face or neck.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Uses of Emgrast M Injection
- Prevention of Infections after chemotherapy
Benefits of Emgrast M Injection
In Prevention of Infections after chemotherapy
Emgrast M 500mcg Injection increases the production of white blood cells by stimulating the immune system in our body. White blood cells are those cells that help us to fight infections. This medicine is really effective and must be used under medical supervision. Avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to.
Side effects of Emgrast M Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Emgrast M
- Bone pain
- Decreased blood pressure
- Rash
- Diarrhea
- Fever
- Breathlessness
- Feeling of discomfort
- Vomiting
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Nausea
- Flu-like symptoms
How to use Emgrast M Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Emgrast M Injection works
Emgrast M 500mcg Injection is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Emgrast M 500mcg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Emgrast M 500mcg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Emgrast M 500mcg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
CONSULT YOUR DOCTOR
It is not known whether Emgrast M 500mcg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
CAUTION
Emgrast M 500mcg Injection should be used with caution in patients with kidney disease. Dose adjustment of Emgrast M 500mcg Injection may be needed. Please consult your doctor.
Regular monitoring of kidney function tests is advised while you are taking this medicine.
Regular monitoring of kidney function tests is advised while you are taking this medicine.
Liver
CAUTION
Emgrast M 500mcg Injection should be used with caution in patients with liver disease. Dose adjustment of Emgrast M 500mcg Injection may be needed. Please consult your doctor.
Regular monitoring of liver function tests is advised while you are taking this medicine.
Regular monitoring of liver function tests is advised while you are taking this medicine.
What if you forget to take Emgrast M Injection?
If you miss a dose of Emgrast M 500mcg Injection, please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Emgrast M 500mcg Injection is given as an injection into a vein or under the skin by the healthcare provider only.
- Do not skip any dose and complete the course as suggested by your doctor.
- Use an effective method of birth control to avoid pregnancy while taking this medication.
- Your doctor may get regular blood tests done to monitor your blood cell count and liver function.
- Inform your doctor if you experience fever, chills, sore throat and shortness of breath during the treatment.
- Emgrast M 500mcg Injection is given as an injection into a vein or under the skin by the healthcare provider only.
- Do not skip any dose and complete the course as suggested by your doctor.
- Use an effective method of birth control to avoid pregnancy while taking this medication.
- Your doctor may get regular blood tests done to monitor your blood cell count and liver function.
- Inform your doctor if you experience fever, chills, sore throat and shortness of breath during the treatment.
Fact Box
Chemical Class
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
Interaction with drugs
Taking Emgrast M with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Do not consume Carboplatin from 1 day before until 1 day after taking Sargramostim. Please consult your doctor.
Concurrent use may cause a decrease in the ability of the bone marr
Do not consume Azathioprine from 1 day before until 1 day after taking Sargramostim. Please consult your doctor.
Concurrent use may cause a decrease in the ability of the bone mar
Do not consume Bendamustine from 1 day before until 1 day after taking Sargramostim. Please consult your doctor.
Concurrent use may cause a decrease in the ability of the bone mar
Do not consume Capecitabine from 1 day before until 1 day after taking Sargramostim. Please consult your doctor.
Concurrent use may cause a decrease in the ability of the bone mar
Do not consume Cladribine from 1 day before until 1 day after taking Sargramostim. Please consult your doctor.
Concurrent use may cause a decrease in the ability of the bone marro
Patient concerns
User feedback
Patients taking Emgrast M 500mcg Injection
Once A Month
43%
Once A Day
29%
Alternate Day
14%
Twice A Week
14%
What are you using Emgrast M Injection for?
Others
50%
Infection pre*
50%
*Infection prevention for chemotherapy
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Masters SB. Agents Used in Anemias; Hematopoetic Growth Factors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 581-82.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1247-48.
Marketer details
Name: Emcure Pharmaceuticals Ltd
Address: 255/2, Hinjawadi, Pune - 411057, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
₹3088
Inclusive of all taxes
MRP₹3358.13 8% OFF
1.0 Injection in 1 vial
SOLD OUT